Yes, it was a play to attract investors and also potential Pharma partners. Nobody bit. Maybe someday someone will. You never know. It’s common for pre-commercialization companies to try and attract attention this way. It’s not worth much unless someone then invests in the company to get human trials started.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links